pantoprazole has been researched along with Rhabdomyolysis in 4 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 75-year-old man developed rhabdomyolysis and acute renal failure during atorvastatin therapy." | 7.78 | Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction. ( Bacic-Vrca, V; Bozina, N; Horvatic, I; Lisicic, A; Marusic, S, 2012) |
| "Polymyositis occurring in patients treated with omeprazole has been signalled as a possible adverse drug reaction (ADR) by the New Zealand Intensive Medicines Monitoring Programme (IMMP) and the WHO Collaborating Centre for International Drug Monitoring: the Uppsala Monitoring Centre (UMC)." | 4.83 | Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? ( Clark, DW; Strandell, J, 2006) |
| "A 75-year-old man developed rhabdomyolysis and acute renal failure during atorvastatin therapy." | 3.78 | Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction. ( Bacic-Vrca, V; Bozina, N; Horvatic, I; Lisicic, A; Marusic, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marusic, S | 1 |
| Lisicic, A | 1 |
| Horvatic, I | 1 |
| Bacic-Vrca, V | 1 |
| Bozina, N | 1 |
| Clark, DW | 1 |
| Strandell, J | 1 |
| Yusoff, IF | 1 |
| Nairn, P | 1 |
| Morgan, CA | 1 |
| Dehesa, C | 1 |
| Kassel, G | 1 |
1 review available for pantoprazole and Rhabdomyolysis
| Article | Year |
|---|---|
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adverse Drug Reaction Reporting Systems; Enzyme Inhibitors; | 2006 |
3 other studies available for pantoprazole and Rhabdomyolysis
| Article | Year |
|---|---|
Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Aged; Aryl Hydrocarbon Hydroxylases; A | 2012 |
Multiple organ failure related to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acidosis, Lactic; Acute Kidney Injury; Aged; Anti-Ulcer Age | 1999 |
Multiple organ failure and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Humans; Multiple Organ F | 2000 |